Updated February 9 at 12:27am
Biotechnology
46 results total, viewing 21 - 30
I’m seeing lots of news reports about the end of the new Silicon Valley tech “bubble.” I put that word in quotes because the current situation doesn’t look much like the bubble of the late 1990s. But there still might soon be a broad drop in funding for startups, and a fall in the valuations of these companies. more
A biomedical engineering professor at the University of Rhode Island has received a $6 million National Science Foundation grant for research to show how the nervous system functions in health and disease. more
Twenty-six Real Jobs RI grant recipients were announced Monday by Gov. Gina M. Raimondo and the congressional delegation. more
Amgen Inc. won U.S. approval for its powerful cholesterol-lowering drug Repatha for certain patients, making it the second in a new class of treatments to come to market. more
Gov. Gina M. Raimondo and Commerce Secretary Stefan Pryor launched three new incentive programs on Wednesday in an effort to grow the state’s economy. more
CVS Health Corp. pays among the highest taxes in the nation, according to WalletHub, which released its S&P 100 tax rates report on Wednesday. more
Tivorsan Pharmaceuticals Inc. has named James E. Connolly CEO. The biotechnology company, which focuses on treating Duchenne Muscular Dystrophy and other neuromuscular disorders, also said that Connolly will serve as a member of its board. more
Mnemosyne Pharmaceuticals has changed its name to Luc Therapeutics and moved its headquarters from Providence to Cambridge. more
The University of Rhode Island has received five grants totaling $629,550 from The Champlin Foundations. more
The Providence Children’s Museum has received a $40,000 grant from the Amgen Foundation to support hands-on science, technology, engineering and math activities. more
« Prev | 1 | 2 | 3 | 4 | 5 Next »